ClinicalTrials.Veeva

Menu

Frequency of Florid Hyperthyroidism In Patients Taking Iodinated Salt (I2 and thyroid)

S

Services Institute of Medical Sciences, Pakistan

Status

Unknown

Conditions

Thyroid Dysfunction

Study type

Observational

Funder types

Other

Identifiers

NCT04809454
1241985

Details and patient eligibility

About

Thyroxin a vital hormone for life lot of body functions depend on proper functioning on pituitary thyroid axis. it exists in two major forms Thyroxine (T4) and (T3) , each of them containing two iodine atoms on their inner (tyrosine) ring. Synthesis of reasonable quantities of thyroid hormones requires adequate iodine intake to allow sufficient thyroidal uptake. The World Health Organization (WHO) recommendation for daily intake of iodine is 150 μg for children ≥12 years and adults, and 250 μg for pregnant and lactating women. However as we know optimum amount of iodine is required for normal pituitary thyroid axis like wise excessive intake may cause over functioning of axis hence over production of hormone that can be manifested both clinically and biochemically.

This study is designed to observe the frequency of over hyperthyroidism in patients taking iodinated salt.

Full description

All patients presenting to endocrine clinic fulfilling inclusion and exclusion criteria will be recruited. They will be examined, their vitals including blood pressure pulse will be noted, thyroid clinical examination including eye signs and thyroid status will be done biochemical Thyroid profile (TSH, Free T3 & Free T4) will be noted in predesigned proforma.

Statistical Analysis will be done ,after data is entered in Statistical Package for the Social Sciences (SPSS) version 25 .qualitative data will be presented as frequencies and percentages while quantitative data will be presented as mean medians and standard deviations.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. All patients presenting with biochemical hyperthyroidism
  2. Who are taking Iodinated salt.
  3. Treatment naïve patients
  4. Both genders included
  5. All patients who can give consent (18-60 years)

Exclusion criteria

  1. Pregnant females 2) Lactating mothers

Trial contacts and locations

1

Loading...

Central trial contact

Amna Rizvi, FCPS Endocrinology; Mehwish Iftikhar, FCPS Endocrinologyy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems